Axogen Balance Sheet
NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Axogen financial position
At the end of fiscal 2025, Axogen reported total assets of $221.7 million, up 8.8% from a year earlier against total liabilities of $92.8 million. Shareholders' equity stood at $128.8 million, or 58.1% of assets. The company held $35.5 million in cash and equivalents against $48.4 million of debt, a net debt position of $12.8 million.
The current ratio (current assets divided by current liabilities) was 5.11, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.38.
Summary generated from market data by MetaCap's automated system. Methodology
Axogen balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 35.55M | 27.55M | 31.02M | 15.28M | 32.76M | 48.77M | 35.72M | 24.29M | 36.51M | 30.01M |
| Short-Term Investments | 5.98M | 5.93M | 0 | 33.51M | 51.33M | 55.20M | 60.79M | 92.31M | — | — |
| Receivables | 26.17M | 24.11M | 25.15M | 22.19M | 18.16M | 17.62M | 16.94M | 15.32M | 11.06M | 8.05M |
| Inventory | 42.37M | 33.18M | 23.02M | 18.91M | 16.69M | 12.53M | 13.86M | 11.98M | 7.32M | 5.46M |
| Total Current Assets | 120.42M | 99.22M | 88.00M | 98.08M | 127.05M | 145.25M | 135.02M | 150.95M | 55.74M | 44.04M |
| Property, Plant & Equipment | 81.78M | 84.67M | 88.73M | 79.29M | 62.88M | 38.40M | 14.89M | 8.04M | 2.20M | 1.49M |
| Intangible Assets | 6.75M | 5.58M | 4.53M | 3.65M | 2.86M | 2.05M | 1.51M | 1.18M | 937.00K | 828.98K |
| Total Assets | 221.69M | 203.73M | 196.83M | 195.39M | 208.02M | 201.38M | 154.64M | 160.17M | 58.88M | 46.36M |
| Accounts Payable | 2.89M | 8.01M | 11.77M | 8.96M | 5.92M | 4.60M | 8.26M | 4.52M | 3.24M | 3.61M |
| Short-Term Debt | — | — | — | — | — | — | 1.74M | 28.00K | 735.00K | 20.90K |
| Total Current Liabilities | 23.56M | 30.61M | 30.43M | 23.75M | 24.29M | 22.83M | 20.88M | 13.04M | 13.72M | 11.08M |
| Long-Term Debt | 48.39M | 47.50M | 46.60M | 45.71M | 44.82M | 32.03M | 0 | 35.00K | 19.81M | 20.27M |
| Total Liabilities | 92.84M | 99.82M | 101.16M | 94.39M | 95.47M | 78.23M | 22.49M | 13.19M | 33.69M | 31.44M |
| Shareholders' Equity | 128.85M | 103.91M | 95.67M | 101.00M | 112.55M | 123.15M | 132.15M | 146.98M | 25.18M | 14.92M |
| Retained Earnings | -306.96M | -291.26M | -281.30M | -259.58M | -230.63M | -203.65M | -179.86M | -150.73M | -128.33M | -117.88M |
| Total Debt | 48.39M | 47.50M | 46.60M | 45.71M | 44.82M | 32.03M | 1.74M | 63.00K | 20.55M | 20.29M |
| Net Cash (Debt) | -6.86M | -14.01M | -15.58M | 3.08M | 39.27M | 71.94M | 94.77M | 116.54M | 15.96M | 9.73M |
| Shares Outstanding | 47.20M | 44.15M | 43.12M | 42.45M | 41.74M | 40.62M | 39.59M | 38.90M | 34.35M | 33.01M |
This table shows 10 annual periods of Axogen's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow AXGN's reporting calendar. What is a balance sheet?